Meropenem and Ticar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meropenem (meropenem) and Ticar (ticarcillin disodium). Common drug interactions include dizziness among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Meropenem and Ticar. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

What is Ticar?

Ticar has active ingredients of ticarcillin disodium. eHealthMe is studying from 275 Ticar users. Check the latest studies of Ticar.

On Jul, 18, 2026

18 people who take Meropenem and Ticar together, and have interactions are studied.

What are the common drug interactions of Meropenem and Ticar, by gender? *:

female:

Dizziness
Hyperkalaemia (damage to or disease of the kidney)
Muscle spasms (muscle contraction)

male:

Arthralgia (joint pain)
Back pain
Hepatotoxicity (chemical-driven liver damage)
Hyperammonaemia
Infection
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Osteoporosis (bones weak and more likely to break)
Pancreatitis acute (sudden inflammation of pancreas)
Systolic dysfunction (impaired ventricular contraction)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the common drug interactions of Meropenem and Ticar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Abdominal pain
Adenovirus infection
Bacterial infection
Diarrhoea
Infection
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Pancreatitis acute (sudden inflammation of pancreas)
Vomiting

10-19:

Arthralgia (joint pain)
Back pain
Osteonecrosis (death of bone)
Congestive cardiomyopathy (weakening of heart muscle)
Diastolic dysfunction
Dyspnoea exertional (breathlessness or shortness of breath)
Osteoporosis (bones weak and more likely to break)
Systolic dysfunction (impaired ventricular contraction)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Drug ineffective
Multiple-drug resistance
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
Hepatotoxicity (chemical-driven liver damage)
Hyperammonaemia
Renal failure (kidney dysfunction)

40-49:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Cytolytic hepatitis (dissolution or destruction of a liver cell)

50-59:

Depressed mood
Electrocardiogram qt prolonged
Neuropathy peripheral (surface nerve damage)
Skin discolouration (change of skin colour)

60+:

Clostridium bacteraemia (presence of clostridium bacteria in the blood)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 16.67%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 11.11%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 5.56%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 5.56%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 1 person, 5.56%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 5.56%
Pulmonary Tuberculosis (lungs tuberculosis): 1 person, 5.56%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 5.56%
Pneumonia: 1 person, 5.56%
Neuralgia (pain in one or more nerves): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and Ticar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously